The European Medicines Agency (EMA) is a decentralized agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU. It ensures that medicines available in the EU are safe, effective, and of high quality.
The European Medicines Agency (EMA) is the EU's agency for the evaluation of medicinal products. It is responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the EU. The EMA's mission is to protect and promote public and animal health through the evaluation and supervision of medicines for use in the European Union. The agency is located in Amsterdam, the Netherlands, and operates with a commitment to transparency and scientific excellence. It plays a crucial role in advancing safe, ethical, and aligned AI practices across the medicines lifecycle and provides regulatory guidance. The EMA works closely with national regulatory authorities in EU Member States to ensure a harmonized approach to medicine regulation across the Union. It also engages with international partners to promote global standards for medicine quality, safety, and efficacy.
About
**Who they are** Regulatory Partners Switzerland is a specialized provider of Swiss Authorized Representative services. They focus on ensuring medical devices and other regulated products comply with Swiss market requirements.
**Expertise & scope** * Facilitating market access for manufacturers seeking to place products on the Swiss market. * Acting as the legally required Swiss Authorized Representative. * Ensuring compliance with Swiss regulations, including the Swiss Medical Devices Ordinance (MedeO). * Providing a local point of contact for Swiss authorities and market surveillance.
**Reputation / proof points** * Established presence in Switzerland to fulfill regulatory obligations.
Additional information
For manufacturers entering the Swiss market, understanding the specific requirements of the Swiss MedeO is crucial. Regulatory Partners Switzerland acts as your local entity, bridging the gap between your company and Swiss regulatory authorities. This ensures that your products meet all local labeling, documentation, and post-market surveillance obligations, facilitating a smoother market entry and ongoing compliance. Their services are designed to manage the complexities of Swiss regulatory representation, allowing you to focus on your core business.
Companies needing to ensure compliance with Swiss MedeO regulations
How engagement typically works
Local representation for Swiss market access
Compliance management and regulatory support
Typical deliverables
Designation as Swiss Authorized Representative
Support for regulatory submissions and inquiries
Assistance with post-market surveillance obligations
Good to know
Best when the primary need is to establish a legal presence and ensure compliance within Switzerland.
HQ: Amsterdam, NL
Languages: English, German, French
Timezones: Europe/Zurich
Claim status: Listed
Services & Capabilities
Best CH-REP (Swiss Authorized Rep) | Compare & Get Quotes
Jurisdictions: CH
Countries: CH
Industries: Medical devices, IVD
Portfolio: 6-25
Onboarding time: 3–10 days
Pricing model: Custom pricing
Starting from: CHF 2,000
Included services: Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability
Device Classes Supported: Class I, Class IIa, Class IIb, Class III, IVD
Vigilance Contact Support: Yes
Swiss Entity Canton Or Region: Zurich
Additional ch_rep Details
Device Classes Supported
All
Supports MDR
false
Supports IVDR
false
Swiss Entity Canton Or Region
Zurich
Labeling Support
true
Swiss Local Contact
true
Vigilance Contact Support
true
Can Be Named On Label
true
Onboarding Steps
Formal appointment as Swiss Authorized Representative, requiring an agreement and provision of necessary documentation to ensure compliance with Swiss regulations.